TCR2 THERAPEUTICS INC's ticker is and the CUSIP is 87808K956. A total of 2 filers reported holding TCR2 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 100 | -99.9% | 0.00% | – |
| Q4 2022 | $146 | -99.9% | 147,000 | -7.7% | 0.00% | – |
| Q3 2022 | $286,000 | -31.1% | 159,300 | +11.2% | 0.00% | – |
| Q2 2022 | $415,000 | +5828.6% | 143,200 | +5407.7% | 0.00% | – |
| Q1 2022 | $7,000 | -56.2% | 2,600 | -27.8% | 0.00% | – |
| Q4 2021 | $16,000 | -69.2% | 3,600 | +14900.0% | 0.00% | – |
| Q1 2021 | $52,000 | -53.2% | 24 | -33.3% | 0.00% | – |
| Q4 2020 | $111,000 | +44.2% | 36 | -5.3% | 0.00% | – |
| Q3 2020 | $77,000 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 36 | $111,000 | 0.00% |